BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33073957)

  • 1. MiR-429 and MiR-143-3p Function as Diagnostic and Prognostic Markers for Osteosarcoma.
    Yang L; Li H; Huang A
    Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Serum miR-337-3p, miR-484, miR-582, and miR-3677 as Promising Biomarkers for Osteosarcoma.
    Luo H; Ye Z
    Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.
    Yu Y; Wang L; Li Z; Zheng Y; Shi Z; Wang G
    J Biochem Mol Toxicol; 2021 May; 35(5):e22734. PubMed ID: 33522065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q; Song S; Ni G; Li Y; Wang X
    Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
    Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
    Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma.
    Yi X; Wang Y; Xu S
    J Orthop Surg Res; 2020 Oct; 15(1):454. PubMed ID: 33008443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
    Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
    Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
    Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
    Cancer Biomark; 2019; 25(1):1-10. PubMed ID: 31006663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma.
    Pang PC; Shi XY; Huang WL; Sun K
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3765-3769. PubMed ID: 27735043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma.
    Zhang C; Yao C; Li H; Wang G; He X
    Int J Clin Exp Pathol; 2014; 7(7):4194-203. PubMed ID: 25120799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-5195-3p Suppresses Cell Proliferation and Induces Apoptosis by Directly Targeting NEDD9 in Osteosarcoma.
    Wang L; Shi G; Zhu D; Jin Y; Yang X
    Cancer Biother Radiopharm; 2019 Aug; 34(6):405-412. PubMed ID: 31411930
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum miR-95-3p is a diagnostic and prognostic marker for osteosarcoma.
    Niu J; Sun Y; Guo Q; Niu D; Liu B
    Springerplus; 2016; 5(1):1947. PubMed ID: 27917340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.
    Zhou S; Wang B; Hu J; Zhou Y; Jiang M; Wu M; Qin L; Yang X
    Tumour Biol; 2016 Jul; 37(7):9001-7. PubMed ID: 26758431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.
    Yao ZS; Li C; Liang D; Jiang XB; Tang JJ; Ye LQ; Yuan K; Ren H; Yang ZD; Jin DX; Zhang SC; Ding JY; Tang YC; Xu JX; Chen K; Xie WX; Guo DQ; Cui JC
    Cancer Biomark; 2018; 22(1):127-133. PubMed ID: 29630525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.
    Xu SH; Yang YL; Han SM; Wu ZH
    World J Surg Oncol; 2014 Jun; 12():195. PubMed ID: 24969351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_0081001 down-regulates miR-494-3p to enhance BACH1 expression and promotes osteosarcoma progression.
    Liu S; Duan K; Zhang X; Cao X; Wang X; Meng F; Liu H; Xu B; Wang X
    Aging (Albany NY); 2021 Jun; 13(13):17274-17284. PubMed ID: 34191748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00319 promotes osteosarcoma progression by regulating the miR-455-3p/NFIB axis.
    Sun F; Yu Z; Wu B; Zhang H; Ruan J
    J Gene Med; 2020 Nov; 22(11):e3248. PubMed ID: 32621625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.